These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

142 related items for PubMed ID: 2257185

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Oxandrolone in girls with Turner's syndrome. A pair-matched controlled study up to final height.
    Joss E, Zuppinger K.
    Acta Paediatr Scand; 1984 Sep; 73(5):674-9. PubMed ID: 6385611
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Combined therapy with growth hormone and oxandrolone in adolescent girls with Turner syndrome.
    Lu PW, Cowell CT.
    J Paediatr Child Health; 1993 Feb; 29(1):40-2. PubMed ID: 8461179
    [Abstract] [Full Text] [Related]

  • 7. Favorable final height outcome in girls with Ullrich-Turner syndrome treated with low-dose growth hormone together with oxandrolone despite starting treatment after 10 years of age.
    Stahnke N, Keller E, Landy H, Serono Study Group.
    J Pediatr Endocrinol Metab; 2002 Feb; 15(2):129-38. PubMed ID: 11874177
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Growth hormone therapy in Turner's syndrome: an update on final height. Genentech National Cooperative Study Group.
    Rosenfeld RG.
    Acta Paediatr Suppl; 1992 Sep; 383():3-6; discussion 7. PubMed ID: 1458013
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Three-year results of a randomized prospective trial of methionyl human growth hormone and oxandrolone in Turner syndrome.
    Rosenfeld RG, Hintz RL, Johanson AJ, Sherman B, Brasel JA, Burstein S, Chernausek S, Compton P, Frane J, Gotlin RW.
    J Pediatr; 1988 Aug; 113(2):393-400. PubMed ID: 3397807
    [Abstract] [Full Text] [Related]

  • 14. Final height of patients with Turner's syndrome treated with growth hormone (GH): indications for GH therapy alone at high doses and late estrogen therapy. Italian Study Group for Turner Syndrome.
    Cacciari E, Mazzanti L.
    J Clin Endocrinol Metab; 1999 Dec; 84(12):4510-5. PubMed ID: 10599710
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Effect of oxandrolone and timing of pubertal induction on final height in Turner syndrome: final analysis of the UK randomised placebo-controlled trial.
    Gault EJ, Cole TJ, Casey S, Hindmarsh PC, Betts P, Dunger DB, Donaldson MDC.
    Arch Dis Child; 2021 Jan; 106(1):74-76. PubMed ID: 31862699
    [Abstract] [Full Text] [Related]

  • 18. Oxandrolone therapy in patients with Turner syndrome.
    Urban MD, Lee PA, Dorst JP, Plotnick LP, Migeon CJ.
    J Pediatr; 1979 May; 94(5):823-7. PubMed ID: 448501
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Growth hormone in combination with anabolic steroids in patients with Turner syndrome: effect on bone maturation and final height.
    Haeusler G, Schmitt K, Blümel P, Plöchl E, Waldhör T, Frisch H.
    Acta Paediatr; 1996 Dec; 85(12):1408-14. PubMed ID: 9001649
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.